Mechanism of atherosclerosis/growth factors

Citations 141-150 of 200 total displayed.

Past content (since Jan 1999):

Scientific Contributions
Hepatocyte Growth Factor and Left Ventricular Geometry in End-Stage Renal Disease

Lorenzo S. Malatino, Alessandro Cataliotti, Francesco A. Benedetto, Benedetta Stancanelli, Ignazio Bellanuova, Paola Belluardo, Lorena Bonaiuto, Giovanni Tripepi, Francesca Mallamaci, Pietro Castellino, and Carmine Zoccali
Hypertension 2003;41:88-92; published online before print as doi:10.1161/01.HYP.0000046919.41112.4B [Abstract] [Full text]  

Scientific Contributions
Molecular Mechanisms Mediating Inflammation in Vascular Disease. Special Reference to Monocyte Chemoattractant Protein-1

Kensuke Egashira
Hypertension published December 30, 2002, doi:10.1161/01.HYP.0000051642.65283.36 [Abstract]  

Scientific Contributions
Hepatocyte Growth Factor and Left Ventricular Geometry in End-Stage Renal Disease

Lorenzo S. Malatino, Alessandro Cataliotti, Francesco A. Benedetto, Benedetta Stancanelli, Ignazio Bellanuova, Paola Belluardo, Lorena Bonaiuto, Giovanni Tripepi, Francesca Mallamaci, Pietro Castellino, and Carmine Zoccali
Hypertension published December 2, 2002, doi:10.1161/01.HYP.0000046919.41112.4B [Abstract]  

Scientific Contributions
ACE Inhibition Versus Angiotensin Type 1 Receptor Antagonism: Differential Effects on PAI-1 Over Time

Nancy J. Brown, Sandeep Kumar, Corrie A. Painter, and Douglas E. Vaughan
Hypertension 2002;40:859-865; published online before print as doi:10.1161/01.HYP.0000040264.15961.48 [Abstract] [Full text]  

Scientific Contributions
PPAR Activator Effects on Ang II–Induced Vascular Oxidative Stress and Inflammation

Quy N. Diep, Farhad Amiri, Rhian M. Touyz, Jeffrey S. Cohn, Dierk Endemann, Mario Fritsch Neves, and Ernesto L. Schiffrin
Hypertension 2002;40:866-871; published online before print as doi:10.1161/01.HYP.0000037969.41360.CC [Abstract] [Full text]  

Scientific Contributions
Antiinflammatory and Antiarteriosclerotic Effects of Pioglitazone

Minako Ishibashi, Kensuke Egashira, Ken-ichi Hiasa, Shujiro Inoue, Weihua Ni, Qingwei Zhao, Makoto Usui, Shiro Kitamoto, Toshihiro Ichiki, and Akira Takeshita
Hypertension 2002;40:687-693; published online before print as doi:10.1161/01.HYP.0000036396.64769.C2 [Abstract] [Full text]  

Scientific Contributions
Leptin Induces Endothelial Cell Migration Through Akt, Which Is Inhibited by PPAR-Ligands

Stephan Goetze, Anne Bungenstock, Cornelia Czupalla, Friedrich Eilers, Philipp Stawowy, Ulrich Kintscher, Chantel Spencer-Hänsch, Kristof Graf, Bernd Nürnberg, Ronald E. Law, Eckart Fleck, and Michael Gräfe
Hypertension 2002;40:748-754; published online before print as doi:10.1161/01.HYP.0000035522.63647.D3 [Abstract] [Full text]  

Scientific Contributions
ACE Inhibition Versus Angiotensin Type 1 Receptor Antagonism. Differential Effects on PAI-1 Over Time

Nancy J. Brown, Sandeep Kumar, Corrie A. Painter, and Douglas E. Vaughan
Hypertension published October 28, 2002, doi:10.1161/01.HYP.0000040264.15961.48 [Abstract]  

Scientific Contributions
PPAR Activator Effects on Ang II-Induced Vascular Oxidative Stress and Inflammation

Quy N. Diep, Farhad Amiri, Rhian M. Touyz, Jeffrey S. Cohn, Dierk Endemann, Mario Fritsch Neves, and Ernesto L. Schiffrin
Hypertension published October 14, 2002, doi:10.1161/01.HYP.0000037969.41360.CC [Abstract]  

Editorial Commentary
Commentary on Liu et al: Effect of Estrogen and AT₁ Receptor Blocker on Neointima Formation

Edwin K. Jackson
Hypertension 2002;40:448-450; published online before print as doi:10.1161/01.HYP.0000033465.65961.07 [Full text]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20